Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction

Resuscitation

Volumn 78, Issue 3, 2008, Pages 258-264

  Aarsetøy, Hildegunn ^a,b   Pönitz, Volker ^a,b   Nilsen, Odd Bjarte ^a,c   Grundt, Heidi ^a,b   Harris, William S ^d   Nilsen, Dennis W T ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF STAVANGER   (Norway)

^d UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Cardiac arrest; Fatty acids; Ischaemia; Myocardial infarction; Prevention; Ventricular fibrillation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; FEMALE; HEART EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; SEX;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; VENTRICULAR FIBRILLATION;

EID: 48149091259     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2008.04.007     Document Type: Article

References (45)

1. Becker L.B., Smith D.W., and Rhodes K.V. Incidence of cardiac arrest: a neglected factor in evaluating survival rates. Ann Emerg Med 22 1 (1993) 86-91
2. Thomas A.C., Knapman P.A., Krikler D.M., and Davies M.J. Community study of the causes of "natural" sudden death. BMJ 297 (1988) 1453-1456
3. Davies M.J. Anatomic features in victims of sudden coronary death: coronary artery pathology. Circulation 85 1 Suppl. (1992) I-19-I-24
4. Herlitz J., Engdahl J., Svensson L., Young M., Ängquist K.A., and Holmberg S. Changes in demographic factors and mortality after out-of-hospital cardiac arrest in Sweden. Coron Artery Dis 16 1 (2005) 51-57
5. Albert C.M., Ma J., Rifai N., Stampfer M.J., and Ridker P.M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105 (2002) 2595-2599
6. Dekker L.R.C., Bezzina C.R., Henriques J.P.S., et al. Familial sudden death is an important risk factor for primary ventricular fibrillation. A case-control study in acute myocardial infarction patients. Circulation 114 (2006) 1140-1145
7. Gheeraert P.J., De Buyzere M.L., Taeymans Y.M., et al. Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J 27 (2006) 2499-2510
8. Gheeraert P.J., Henriques J.P.S., De Buyzere M.L., et al. Out-of-hospital ventricular fibrillation in patients with acute myocardial infarction. Coronary angiographic determinants. J Am Coll Cardiol 35 (2000) 144-150
9. Abete P., Ferrara N., Cacciatore F., et al. Angina-induced protection against myocardial infarctions in adult and elderly patients: a loss of preconditioning mechanism in the aging heart?. J Am Coll Cardiol 30 (1997) 947-954
10. Gheeraert P.J., Henriques J.P.S., De Buyzere M.L., De Pauw M., Taeymans Y., and Zijlstra F. Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery. J Am Coll Cardiol 38 (2001) 1369-1374
11. Norris R.M., Barnaby P.F., Brown M.A., et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propanolol. Lancet 2 (1984) 883-886
12. Herlitz J., Bahr J., Fischer M., Kuisma M., Lexow K., and Thorgeirsson G. Resuscitation in Europe: a tale of five European regions. Resuscitation 41 (1999) 121-131
13. Mozaffarian D., and Rimm E.B. Fish intake, contaminants and human health. Evaluating the risks and the benefits. JAMA 296 15 (2006) 1885-1899
14. Burr M.L., Fehily A.M., Gilbert J.F., et al. Effects of changes in fat, fish and fibre intakes on death and myocardial infarction: diet and reinfarction trial (DART). Lancet 2 (1989) 757-761
15. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
16. Siscovick D.S., Raghunathan T.E., King I., et al. Dietary intake and cell membrane levels of long chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274 (1995) 1363-1367
17. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346 15 (2002) 1113-1118
18. Harris W.S., Sands S.A., Windsor S.L., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients. Correlation with erythrocytes and response to supplementation. Circulation 110 (2004) 1645-1649
19. Owen A.J., Peter-Przyborowska B.A., Hoy A.J., and McLennan P.L. Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition. Lipids 39 (2004) 955-961
20. Garg M.L., Leitch J., Blake R.J., and Garg R. Long-chain n-3 polyunsaturated fatty acid incorporation into human atrium following fish oil supplementation. Lipids 41 (2006) 1127-1132
21. Leaf A., Xiao Y.F., Kang J.X., and Billman G.E. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacol Ther 98 3 (2003) 355-377
22. 2+ exchange currents in HEK293t cells. Biochem Biophys Res Commun 321 1 (2004) 116-123
23. Reiffel J.A., and McDonald A. Antiarrhythmic effects of omega-3 fatty acids. Am J Cardiol 98 Suppl. (2006) 50i-60i
24. Hodson L., Skeaff C.M., Wallace A.J., and Arribas G.L. Stability of plasma and erythrocyte fatty acid composition during cold storage. Clin Chem Acta 321 (2002) 63-67
25. Marangoni F., Colombo C., and Galli C. A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem 326 2 (2004) 267-272
26. Grubb N.R., Fox K.A.A., and Cawood P. Resuscitation from out-of-hospital cardiac arrest: implication for cardiac enzyme estimation. Resuscitation 33 (1996) 35-41
27. Müllner M., Hirschl M.M., Herkner H., et al. Creatine kinase-MB fraction and cardiac troponin T to diagnose acute myocardial infarction after cardiopulmonary resuscitation. J Am Coll Cardiol 28 (1996) 1220-1225
28. Morrow D.A., Cannon C.P., Jesse R.L., et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53 4 (2007) 552-574
29. Lemaitre R.N., King I.B., Mozaffarian D., Kuller L.H., Tracy R.P., and Siscovick D.S. N-3 polyunsaturated fatty acids, fatal ischemic heart disease, and non-fatal myocardial infarctions in older adults: the Cardiovascular Health Study. Am J Clin Nutr 77 (2003) 319-325
30. Harris W.S., and von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev Med 39 1 (2004) 212-220
31. Cobb L.A., Fahrenbruch C.E., Olsufka M., and Copass M.K. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA 288 (2002) 3008-3013
32. Bunch T.J., White R.D., Friedman P.A., Kottke T.E., Wu L.A., and Packer D.L. Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: A 17-years population-based study. Heart Rhythm 3 (2004) 255-259
33. Müller D., Agrawald R., and Arntz H.R. How sudden is sudden cardiac death?. Circulation 114 (2006) 1146-1150
34. Pepe S., and McLennan P.L. Dietary fish oil confers direct antiarrhythmic properties on the myocardium in rats. J Nutr 126 (1996) 34-42
35. Billman G.E., Kang J.X., and Leaf A. Prevention of ischemia-induced cardiac sudden death by pure n-3 polyunsaturated fatty acids. Circulation 99 (1999) 2452-2457
36. McLennan P.L., Bridle T.M., Abeywardena M.Y., and Charnock J.S. Comparative efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am J Clin Nutr 58 5 (1993) 666-669
37. Matthan N.R., Jordan H., Chung M., Lichtenstein A.H., Lathrop D.A., and Lau J. A systematic review and meta-analysis of the impact of ω-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism 54 12 (2005) 1557-1565
38. Schrepf R., Limmert T., Weber P.C., Theisen K., and Sellmayer A. Immediate effect of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 363 (2004) 1441-1442
39. Christensen J.H., Riahi S., Schmidt E.B., et al. N-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators. Europace 7 4 (2005) 338-344
40. Leaf A., Albert C.M., Josephson M., et al. Prevention of fatal arrhythmias in high risk subjects by fish oil n-3 fatty acid intake. Circulation 112 (2005) 2762-2768
41. Raitt M.H., Connor W.E., Morris C., Kron J., et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. A randomized controlled trial. JAMA 293 (2005) 2884-2891
42. Brouwer I., Zock P., Camm A.J., et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators. The study on omega-3 fatty acids and ventricular arrhythmia (SOFA) randomized trial. JAMA 295 (2006) 2613-2619
43. Jurand J., and Oliver M.F. Effects of acute myocardial infarction and of noradrenaline infusion on fatty acid composition of serum lipids. Atherosclerosis 11 (1970) 157-170
44. Cao J., Schwichtenberg K.A., Hanson N.Q., and Tsai M.Y. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 52 12 (2006) 2265-2272
45. Sullivan B.L., Williams P.G., and Meyer B.J. Biomarker validation of a long-chain omega-3 polyunsaturated fatty acid food frequency questionnaire. Lipids 41 9 (2006) 845-850